Healthcare royalties company Royalty Pharma (NASDAQ:RPRX) fell short of the market’s revenue expectations in Q4 CY2025 as sales rose 4.7% year on year to $622 million. Its GAAP profit of $0.64 per share was 57.3% below analysts’ consensus estimates.

The silver market will be in deficit for a sixth consecutive year, according to a report published by the Silver Institute, as surging investment outweighs wilting demand for jewelry and efforts to curb use in the solar sector. Silver has been on a wild

Packaged foods company Kraft Heinz (NASDAQ:KHC) met Wall Street’s revenue expectations in Q4 CY2025, but sales fell by 3.4% year on year to $6.35 billion. Its non-GAAP profit of $0.67 per share was 9.1% above analysts’ consensus estimates.

Danaher has underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.

Interactive software platform Unity (NYSE:U) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 10.1% year on year to $503.1 million. On the other hand, next quarter’s revenue guidance of $485 million was less impressive,

E-commerce platform Shopify (NYSE:SHOP) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 30.6% year on year to $3.67 billion. Its GAAP profit of $0.57 per share was 33.9% above analysts’ consensus estimates.

Builders FirstSource has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.

Construction materials supplier Martin Marietta Materials (NYSE:MLM) missed Wall Street’s revenue expectations in Q4 CY2025, with sales falling 6% year on year to $1.53 billion. The company’s full-year revenue guidance of $6.6 billion at the midpoint came

Shopify projected quarterly revenue well above market estimates on Wednesday, as the e-commerce platform benefits from resilient consumer spending against ‌a backdrop of U.S. tariffs and rising prices. While U.S. President Donald Trump's tariffs, rising

Phillips 66 has outperformed the broader market over the past year, and analysts are moderately optimistic about the stock’s prospects.

Humana has notably underperformed the broader market over the past year, and analysts are cautious about the stock’s prospects.

Health insurance company Humana (NYSE:HUM) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 11.4% year on year to $32.52 billion. Its GAAP loss of $6.61 per share was 62.2% below analysts’ consensus estimates.

Precision measurement and sensing technologies provider Vishay Precision (NYSE:VPG) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 10.9% year on year to $80.57 million. On the other hand, next quarter’s revenue guidan

March S&P 500 E-Mini futures (ESH26) are trending up +0.10% this morning as investors await the release of the U.S. nonfarm payrolls report, which is crucial for shaping expectations about the Federal Reserve’s interest-rate path.

Life sciences company Avantor (NYSE:AVTR) reported Q4 CY2025 results exceeding the market’s revenue expectations, but sales fell by 1.4% year on year to $1.66 billion. Its non-GAAP profit of $0.22 per share was in line with analysts’ consensus estimates.